FOXO4-DRI
$249.99
<strong>FOXO4-DRI</strong> is a synthetic peptide designed to disrupt the FOXO4–p53 protein interaction. In vitro and rodent-model studies have examined its effects on senescent cell populations, p53 localization, and inflammatory markers in aged tissue. Mechanistic work centres on displacement of p53 from FOXO4 and subsequent apoptosis in senescent cells. Published research is limited and has seen little independent replication.
<div class="plp-specs">
<p class="plp-specs-label">Research Areas</p>
<ul class="plp-specs-list">
<li>FOXO4–p53 Displacement</li>
<li>Senescent Cell Assays</li>
<li>p53 Localization Studies</li>
<li>Apoptosis Models</li>
<li>Limited Independent Replication</li>
<li>In Vitro & Animal Models</li>
</ul>
</div>
<strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong>
Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.
PEG-MGF
$89.99
<p><strong>PEG-MGF</strong> is a pegylated form of Mechano Growth Factor, a splice variant of IGF-1. Preclinical studies have examined its association with satellite cell activation, myoblast proliferation, and skeletal muscle tissue models following mechanical loading. PEGylation extends plasma half-life relative to native MGF in animal models.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>Satellite Cell Activation</li><li>Myoblast Proliferation</li><li>Mechanical Loading Models</li><li>IGF-1 Pathway Studies</li><li>PEGylation Half-Life Profile</li><li>In Vitro & Animal Models</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
Reconstitution Solution – for Laboratory Use
$11.99 – $16.99Price range: $11.99 through $16.99
<p><strong>Bacteriostatic Water</strong> is a sterile, non-pyrogenic solution containing 0.9% benzyl alcohol as a preservative. It is the standard solvent used in laboratory settings for reconstituting and storing lyophilized research peptides. The benzyl alcohol inhibits bacterial growth, permitting repeated withdrawals from a single vial while maintaining sterility.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>Sterile & Pyrogen-Free</li><li>0.9% Benzyl Alcohol Preservative</li><li>Multi-Withdrawal Compatible</li><li>Standard Reconstitution Solvent</li><li>Laboratory Grade</li><li>Research Supply</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
DSIP
$54.99
<p><strong>DSIP</strong> (Delta Sleep-Inducing Peptide) is a synthetic nonapeptide first isolated from rabbit cerebral venous blood. Animal-model studies have examined its association with slow-wave sleep architecture and hypothalamic–pituitary–adrenal axis signalling. Findings across the literature are inconsistent, and its endogenous role remains debated.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>Slow-Wave Sleep Architecture</li><li>HPA Axis Signaling</li><li>Corticotropin Studies</li><li>EEG Model Research</li><li>Findings Inconsistent Across Literature</li><li>In Vitro & Animal Models</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
SS-31
$74.99 – $229.99Price range: $74.99 through $229.99
<p><strong>SS-31</strong> (elamipretide) is a synthetic tetrapeptide with affinity for cardiolipin on the inner mitochondrial membrane. Preclinical work has examined its effects on mitochondrial bioenergetics, reactive oxygen species production, and cristae morphology in models of ischemia-reperfusion injury, heart failure, and mitochondrial myopathy. Elamipretide has been evaluated in human clinical trials; primary endpoints have not been consistently met.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>Cardiolipin Binding</li><li>Mitochondrial Bioenergetics</li><li>ROS Production Assays</li><li>Cristae Morphology</li><li>Evaluated in Human Trials — Endpoints Mixed</li><li>In Vitro & Animal Models</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
CJC-1295, Ipamorelin
$89.99
<p><strong>CJC-1295 + Ipamorelin</strong> pairs a GHRH analog with a selective ghrelin-receptor (GHS-R1a) agonist. The two act on pituitary somatotrophs via distinct receptors, and preclinical studies have examined their combined effect on pulsatile GH release and IGF-1 response in animal models. Published comparisons report low activity at cortisol and prolactin pathways for Ipamorelin relative to earlier GHRPs. The combination has not been evaluated as a single formulation in peer-reviewed literature.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>Distinct Receptor Pathways</li><li>GH Pulsatility Studies</li><li>IGF-1 Response Models</li><li>GHRH Analog Pharmacology</li><li>Component-Level Research Only</li><li>Combination Not Evaluated as a Formulation</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
KLOW
$224.99
<p><strong>KLOW</strong> combines KPV, GHK-Cu, BPC-157, and TB-500. The components have been studied individually: KPV in inflammatory signalling, GHK-Cu in collagen gene expression and copper transport, BPC-157 in angiogenesis and fibroblast migration, and TB-500 in actin sequestration and cell migration. No peer-reviewed study has evaluated this four-compound combination as a single formulation.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>NF-κB Studies (KPV)</li><li>Collagen Expression (GHK-Cu)</li><li>Angiogenesis (BPC-157)</li><li>Actin Sequestration (TB-500)</li><li>Component-Level Research Only</li><li>Combination Not Evaluated as a Formulation</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
GLOW BPC-157 10MG, TB-500 10MG, GHK-CU 50MG
$159.99
<p><strong>GLOW</strong> combines GHK-Cu, BPC-157, and TB-500. Component-level research has examined GHK-Cu in collagen and elastin gene expression, BPC-157 in angiogenesis and fibroblast migration, and TB-500 in actin regulation and cell migration. The combination itself has not been evaluated as a single formulation in peer-reviewed literature.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>Collagen Expression (GHK-Cu)</li><li>Angiogenesis (BPC-157)</li><li>Actin Regulation (TB-500)</li><li>Copper Transport Studies</li><li>Component-Level Research Only</li><li>Combination Not Evaluated as a Formulation</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
5-Amino-1MQ
$49.99 – $95.99Price range: $49.99 through $95.99
<p><strong>5-Amino-1MQ</strong> (5-amino-1-methylquinolinium) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). Preclinical studies have examined its effects on intracellular NAD⁺ pools, adipose tissue substrate handling, and NNMT enzyme kinetics in cell culture and rodent models. Its membrane permeability distinguishes it from earlier NNMT inhibitors.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>NNMT Inhibition Studies</li><li>Intracellular NAD⁺ Pools</li><li>Enzyme Kinetics Assays</li><li>Adipocyte Substrate Handling</li><li>Membrane Permeability</li><li>In Vitro & Animal Models</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
Wolverine Stack BPC/157-TB-500
$74.99 – $99.99Price range: $74.99 through $99.99
<p><strong>The Wolverine Stack</strong> pairs BPC-157 and TB-500. Both appear in connective-tissue and cell-migration research: BPC-157 in angiogenesis and fibroblast migration, TB-500 in G-actin sequestration. The two are frequently combined in research settings, though the combination has not been evaluated as a single formulation in peer-reviewed literature.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>Angiogenesis (BPC-157)</li><li>G-Actin Sequestration (TB-500)</li><li>Connective Tissue Models</li><li>Cell Migration Assays</li><li>Component-Level Research Only</li><li>Combination Not Evaluated as a Formulation</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
ARA-290
$62.99
<p><strong>ARA-290</strong> (cibinetide) is an 11-amino-acid peptide derived from the helix-B domain of erythropoietin. It binds the innate repair receptor without engaging the classical EPO receptor, and therefore does not stimulate erythropoiesis. Clinical trials have examined it in sarcoidosis-associated small-fibre neuropathy; reported endpoints have been mixed.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>Innate Repair Receptor Binding</li><li>EPO Helix-B Domain</li><li>No Erythropoietic Activity</li><li>Tissue-Protective Pathway Studies</li><li>Neuropathy Trial Endpoints Mixed</li><li>In Vitro & Animal Models</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
Tirzepatide – Research Peptide
$89.99 – $249.99Price range: $89.99 through $249.99
<p><strong>Tirzepatide</strong> is a synthetic peptide acting as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Preclinical and clinical literature has examined its receptor binding profile and incretin pathway pharmacology.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>GIP Receptor Binding</li><li>GLP-1 Receptor Binding</li><li>Dual-Agonist Pharmacology</li><li>Incretin Pathway Studies</li><li>Peer-Reviewed Literature</li><li>In Vitro & Animal Models</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
Tesamorelin – Research Peptide
$149.99
<p><strong>Tesamorelin</strong> is a synthetic 44-amino-acid analog of growth hormone-releasing hormone (GHRH). It binds GHRH receptors on pituitary somatotrophs, and preclinical studies have examined GH secretion kinetics, IGF-1 response, and adipose tissue distribution endpoints in animal models.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>GHRH Receptor Binding</li><li>GH Secretion Kinetics</li><li>IGF-1 Response Models</li><li>Adipose Distribution Endpoints</li><li>GHRH Analog Pharmacology</li><li>In Vitro & Animal Models</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
TB-500
$39.99 – $74.99Price range: $39.99 through $74.99
<p><strong>TB-500</strong> is a synthetic fragment corresponding to the actin-binding domain of Thymosin Beta-4. Preclinical studies have examined its role in G-actin sequestration, cell migration, and angiogenesis in dermal, cardiac, and corneal injury models. It is frequently paired with BPC-157 in research contexts. WADA Prohibited List, S2.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>G-Actin Sequestration</li><li>Cell Migration Assays</li><li>Angiogenesis Studies</li><li>Actin Regulation</li><li>Dermal & Corneal Models</li><li>WADA Prohibited List, S2</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
Semax – Research Peptide
$114.99
<p><strong>Semax</strong> is a synthetic analog of the ACTH(4-10) fragment. Preclinical studies have examined its association with BDNF expression, synaptic plasticity markers, and neuronal survival in rodent models of cerebral ischemia. The published literature originates predominantly from Russian institutions and has seen limited independent replication. Not approved by the FDA.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>BDNF Expression Studies</li><li>Synaptic Plasticity Markers</li><li>Cerebral Ischemia Models</li><li>Neuronal Survival Assays</li><li>Predominantly Russian Literature</li><li>Not Approved by the FDA</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
Selank – Research Peptide
$59.99
<p><strong>Selank</strong> is a synthetic analog of the endogenous immunomodulatory peptide Tuftsin. Animal-model studies have examined its effects on GABAergic signalling, monoamine turnover, and anxiety-related behavioural endpoints, reported without the sedation associated with benzodiazepines. As with Semax, the literature is predominantly Russian in origin with limited independent replication. Not approved by the FDA.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>GABAergic Signaling</li><li>Monoamine Turnover</li><li>Behavioral Endpoint Models</li><li>Tuftsin Analog Pharmacology</li><li>Predominantly Russian Literature</li><li>Not Approved by the FDA</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
Retatrutide – Research Peptide
$84.99 – $239.99Price range: $84.99 through $239.99
<p><strong>Retatrutide</strong> is a synthetic peptide acting as a triple agonist at the GIP, GLP-1, and glucagon receptors. Preclinical and clinical literature has examined its receptor binding profile and triple-agonist pharmacology relative to single- and dual-agonist incretin compounds.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>GIP Receptor Binding</li><li>GLP-1 Receptor Binding</li><li>Glucagon Receptor Binding</li><li>Triple-Agonist Pharmacology</li><li>Incretin Pathway Studies</li><li>In Vitro & Animal Models</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
PT-141 (Bremelanotide) – Research Peptide
$79.99
<p><strong>PT-141</strong> (bremelanotide) is a synthetic cyclic heptapeptide and melanocortin receptor agonist, structurally derived from Melanotan II. Preclinical studies have examined its binding at MC3R and MC4R, receptor selectivity, and central nervous system pharmacology in animal models.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>MC3R / MC4R Binding</li><li>Melanocortin Pathway Studies</li><li>Central Nervous System Models</li><li>Receptor Selectivity Assays</li><li>Preclinical Pharmacology</li><li>In Vitro & Animal Models</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
Oxytocin – Research Peptide
$59.99
<p><strong>Oxytocin</strong> is a naturally occurring cyclic nonapeptide synthesized in the hypothalamus. Research has examined its binding at the oxytocin receptor (OXTR), its role in social and maternal behaviour models, and its cross-reactivity with vasopressin receptor pathways. Behavioural endpoints across the literature have been inconsistent, and effect sizes reported in human studies remain debated.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>OXTR Receptor Binding</li><li>Social Behavior Models</li><li>Maternal Behavior Studies</li><li>Neuropeptide Signaling</li><li>Vasopressin Cross-Reactivity</li><li>Endpoints Inconsistent Across Literature</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
NAD+ (Nicotinamide Adenine Dinucleotide) – Research Grade
$169.99
<p><strong>NAD+</strong> (Nicotinamide Adenine Dinucleotide) is a coenzyme central to redox reactions, mitochondrial electron transport, and sirtuin- and PARP-dependent signalling. Tissue NAD+ concentrations decline with age across multiple species. Research examines NAD+ and its precursors (NR, NMN) in metabolic and mitochondrial models. The bioavailability of exogenous NAD+ itself remains a contested question in the literature.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>Redox Reactions</li><li>Electron Transport Chain</li><li>Sirtuin-Dependent Signaling</li><li>PARP Pathway Studies</li><li>Tissue NAD+ Declines With Age</li><li>Exogenous Bioavailability Contested</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
MOTS-c – Research Peptide
$129.99
<p><strong>MOTS-c</strong> is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene, one of several identified mitochondrial-derived peptides. Preclinical studies have examined its effects on AMPK signalling, the folate–methionine cycle, and insulin-signalling endpoints in cell culture and rodent models.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>AMPK Pathway Activation</li><li>Folate–Methionine Cycle</li><li>Insulin Signaling Models</li><li>Metabolic Substrate Studies</li><li>Mitochondrial Genomics</li><li>In Vitro & Animal Models</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
KPV – Research Peptide
$74.99
<p><strong>KPV</strong> (Lys-Pro-Val) is a synthetic tripeptide corresponding to the C-terminal sequence of α-melanocyte-stimulating hormone (α-MSH). In vitro and animal-model research has examined its interaction with NF-κB signaling and epithelial barrier models, and it is studied in inflammation-pathway and immune-signaling research contexts. Supplied as lyophilized powder.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>NF-κB Pathway Studies</li><li>Epithelial Barrier Models</li><li>α-MSH Receptor Signaling</li><li>Cytokine Expression Assays</li><li>Melanocortin Research</li><li>In Vitro & Animal Models</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
Ipamorelin – Research Peptide
$69.99
<p><strong>Ipamorelin</strong> is a selective pentapeptide ghrelin-receptor (GHS-R1a) agonist that stimulates pituitary GH release. Published comparisons with earlier GHRPs report comparatively low activity at ACTH and prolactin pathways. Preclinical studies have examined its effects on GH pulsatility, IGF-1 response, and body-composition endpoints in animal models.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>GHS-R1a Receptor Binding</li><li>GH Pulsatility Studies</li><li>IGF-1 Response Models</li><li>Receptor Selectivity</li><li>Low ACTH / Prolactin Activity</li><li>In Vitro & Animal Models</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
GHK-CU (Copper Peptide) – Premium Research Grade
$89.99
<p><strong>GHK-Cu</strong> (Copper Tripeptide-1) is a naturally occurring copper-binding tripeptide (Glycyl-L-Histidyl-L-Lysine). In vitro and animal-model studies have examined its role in collagen and elastin gene expression, copper transport, and fibroblast activity. Plasma GHK concentrations decline with age in published human data. It appears widely across dermatological and tissue-remodelling research literature.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>Collagen Gene Expression</li><li>Elastin Synthesis Assays</li><li>Copper Transport Studies</li><li>Fibroblast Activity Models</li><li>Plasma GHK Declines With Age</li><li>In Vitro & Animal Models</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
Epitalon – Research Peptide
$149.99
<p><strong>Epithalon</strong> (also called Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal peptide Epithalamin. Studies have examined its association with telomerase activity, telomere length, and melatonin rhythm in cell culture and rodent models. The published literature originates largely from a single research group and has seen limited independent replication.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>Telomerase Activity Assays</li><li>Telomere Length Studies</li><li>Pineal Peptide Research</li><li>Melatonin Rhythm Models</li><li>Limited Independent Replication</li><li>In Vitro & Animal Models</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
CJC-1295 No DAC- Research Peptide
$79.99
<p><strong>CJC-1295 (No DAC)</strong> also called Mod GRF 1-29, is a GHRH analog carrying amino-acid substitutions that resist DPP-4 cleavage. Its shorter half-life relative to the DAC-conjugated form produces a more pulsatile GH profile in animal models. Preclinical studies have examined GH release, IGF-1 response, and co-administration with ghrelin-receptor agonists such as Ipamorelin.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>DPP-4 Resistant Substitutions</li><li>GH Pulsatility Studies</li><li>IGF-1 Response Models</li><li>Short Half-Life Profile</li><li>GHRH Receptor Pharmacology</li><li>In Vitro & Animal Models</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
BPC-157
$42.99 – $64.99Price range: $42.99 through $64.99
<p><strong>BPC-157</strong> is a synthetic pentadecapeptide — a 15-amino-acid partial sequence of body protection compound (BPC), a protein originally isolated from gastric juice. In vitro and animal-model studies have investigated its role in angiogenesis, fibroblast migration, and collagen organization, with proposed mechanisms including VEGFR2 signaling and the FAK-paxillin pathway. Supplied as lyophilized powder.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>Angiogenesis Studies</li><li>Fibroblast Migration</li><li>Collagen Organization</li><li>VEGFR2 Signaling</li><li>FAK–Paxillin Pathway</li><li>In Vitro & Animal Models</li></ul></div>
<p>Independently tested: <strong>>99.95% purity, 99.2% of label</strong>. WADA Prohibited List, S0.</p>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
AOD-9604 – Research Peptide
$129.99
<p><strong>AOD-9604</strong> corresponds to the C-terminal fragment (residues 177–191) of human growth hormone. Preclinical studies have examined its effects on lipolysis and lipogenesis in adipocyte models without the IGF-1 elevation associated with full-length hGH. Human clinical trials conducted by Metabolic Pharmaceuticals did not meet their primary endpoints, and the compound was not approved as a therapeutic.</p>
<div class="plp-specs"><p class="plp-specs-label">Research Areas</p><ul class="plp-specs-list"><li>Lipolysis Assays</li><li>Adipocyte Models</li><li>Lipogenesis Studies</li><li>IGF-1 Independence</li><li>hGH Fragment Pharmacology</li><li>Phase 2b Trials Did Not Meet Endpoints</li></ul></div>
<p><strong>FOR RESEARCH USE ONLY • NOT FOR HUMAN CONSUMPTION</strong><br />Not evaluated by the FDA • Supplied strictly for in vitro laboratory research.</p>
